| View |
|
DR-XY48844
|
Telmisartan + Amlodipine(as besilate)
|
Telmipin
|
80 mg/ 10 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
10 August 2023
|
10 August 2028
|
| View |
DR-XY48771_PI_01.pdf
|
DR-XY48771
|
Budesonide/Glycopyrronium (as bromide)/
Formoterol fumarate (as dihydrate)
|
Breztri Aerosphere
|
160 mcg/7.2 mcg/4.8 mcg per actuation
|
Pressurized Metered-Dose Suspension for Inhalation
|
-
|
AstraZeneca Dunkerque Production.
|
France
|
Monitored Release
|
09 June 2023
|
09 June 2028
|
| View |
|
DRP-13545-01
|
Omeprazole (as sodium)
|
Qerd
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
Renewal
|
01 August 2023
|
08 March 2028
|
| View |
|
DRP-13673-02
|
Ampicillin (as sodium)
|
QLIN
|
500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
Uni Medicolabs
|
India
|
Renewal
|
01 August 2023
|
24 March 2028
|
| View |
|
DRP-13707
|
Rabeprazole Sodium
|
Rabeloc IV
|
20 mg
|
Powder for Solution for Injection (IV)
|
Proton Pump Inhibitors
|
Cadila Pharmaceutical Limited
|
India
|
Renewal
|
08 August 2023
|
28 November 2028
|
| View |
|
DRP-13933-1
|
Clopidogrel (as bisulfate)
|
OP-Reduclot
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Globela Pharma Private Limited
|
India
|
Renewal
|
11 August 2023
|
18 May 2028
|
| View |
|
DRP-13958-2
|
Colistimethate sodium
|
Colistat
|
2,000,000 I.U. (equivalent to 66.67 mg Colistin base)
|
Lyophilized Powder for Injection
|
Antibacterial (Polymyxin)
|
United Biotech Pvt. Ltd.
|
India
|
Renewal
|
15 August 2023
|
25 May 2028
|
| View |
|
DRP-4934-01
|
Omeprazole
|
None
|
10 mg
|
Delayed Release Capsule
|
Proton Pump (H+ K+ ATPase) Inhibitor
|
Interphil Laboratories, Inc
|
Philippines
|
Renewal
|
15 August 2023
|
20 November 2028
|
| View |
|
DRP-4935-03
|
Omeprazole
|
None
|
20 mg
|
Delayed Release Capsule
|
Proton Pump (H+ K+ ATPase) Inhibitor
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
04 August 2023
|
18 November 2028
|
| View |
|
DRP-5280-01
|
Levetiracetam
|
Zolevi
|
1g
|
Film-Coated tablet
|
Anti-epileptic
|
Lek Pharmaceuticals D.D.
|
Slovenia
|
Renewal
|
19 February 2024
|
23 April 2029
|
| View |
|
DRP-5834-05
|
Ceftriaxone (as sodium)
|
Jazfix
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Kyung Dong Pharm Co., Ltd.
|
Korea
|
Renewal
|
07 August 2023
|
12 September 2028
|
| View |
|
DRP-5834-06
|
Ceftriaxone (as sodium)
|
C-Fixon
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Kyung Dong Pharm. Co., Ltd
|
Korea
|
Renewal
|
08 August 2023
|
12 September 2028
|
| View |
|
DRP-7012-02
|
Irbesartan + Hydrochlorothiazide
|
Arten Plus
|
150 mg / 12.5 mg
|
Film-Coated Tablet
|
Angiotensin-II Receptor Blocker / Diuretic
|
Lek Pharmaceuticals D.D.
|
Slovenia
|
Renewal
|
18 August 2023
|
16 October 2028
|
| View |
|
DRP-7486-01
|
Levetiracetam
|
Zolevi
|
250 mg
|
Film-Coated tablet
|
Antiepileptic
|
Lek Pharmaceuticals D.D
|
Slovenia
|
Renewal
|
28 November 2023
|
13 February 2029
|
| View |
|
DRP-7545-02
|
Lactulose
|
None
|
3.33 g/5 mL
|
Oral Solution
|
Laxative/Cathartic
|
UNITED BIOTECH PVT. LTD
|
India
|
Renewal
|
28 August 2023
|
03 October 2028
|
| View |
|
HRP-617-01
|
Salicylic Acid
|
None
|
5%
|
Solution
|
Keratolytic / Antifungal
|
Dann’s Aid Lab. Inc
|
Philippines
|
Renewal
|
15 August 2023
|
01 July 2025
|
| View |
|
DRP-4324-04
|
Clindamycin (as phosphate)
|
Clintam
|
150mg/mL (300 mg/2 mL)
|
Solution for Injection(I.M./I.V.)
|
-
|
MEDICO REMEDIES LIMITED
|
India
|
Renewal
|
07 August 2023
|
28 September 2027
|
| View |
|
DRP-6556-4
|
Nystatin
|
Kodastyn
|
100,000 Units/ mL
|
Oral Suspension
|
-
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
Renewal
|
31 May 2023
|
07 March 2026
|
| View |
|
DR-XY47211
|
Edoxaban (as tosilate)
|
Lixiana
|
15 mg
|
Film-Coated Tablet
|
-
|
Daiichi Sankyo Europe GmbH
|
Germany
|
Monitored Release (MR)
|
29 March 2021
|
29 March 2026
|
| View |
|
DR-XY47212
|
Edoxaban (as tosilate)
|
Lixiana
|
30 mg
|
Film-Coated Tablet
|
-
|
Daiichi Sankyo Europe GmbH
|
Germany
|
Monitored Release (MR)
|
29 March 2021
|
29 March 2026
|